Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization

Claudia Massarotti, Giulia Gentile, Chiara Ferreccio, Paola Scaruffi, Valentino Remorgida, Paola Anserini

Research output: Contribution to journalArticle

Abstract

This study aims to evaluate levels of anxiety and depression in women, correlated with infertility per se and with infertility treatments, highlighting predictors of higher levels of distress. Two validated standardized questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of Life (FertiQoL), were administered to 89 women both before their first cycle of infertility treatment and again at the end of the ovarian stimulation for in vitro fertilization (IVF). Women's levels of anxiety were significantly higher before the treatment than during the treatment itself. Stratifying the women in three groups based on principal cause of infertility (male infertility, female infertility, or both male and female), we found significantly higher levels of anxiety and general distress in patients under treatment for female infertility. Higher anxiety levels in our sample before the treatment are probably an effect of not knowing what they are expected to do to solve their problem. Moreover, when the cause of infertility is exclusively female, women experience higher levels of anxiety and general distress both before and during the treatment, probably correlated to a sense of guilt. These data help the treating physician to better counsel patients and to provide a more focused psychological support.

Original languageEnglish
JournalGynecological Endocrinology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Fertilization in Vitro
Infertility
Anxiety
Quality of Life
Depression
Female Infertility
Therapeutics
Guilt
Ovulation Induction
Male Infertility
Fertility
Psychology
Physicians

Keywords

  • anxiety
  • FertiQoL
  • HADS
  • in vitro fertilization
  • Infertility
  • quality of life

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Obstetrics and Gynaecology

Cite this

Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. / Massarotti, Claudia; Gentile, Giulia; Ferreccio, Chiara; Scaruffi, Paola; Remorgida, Valentino; Anserini, Paola.

In: Gynecological Endocrinology, 01.01.2019.

Research output: Contribution to journalArticle

@article{67ce423ea9fa49adaa683af28201b709,
title = "Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization",
abstract = "This study aims to evaluate levels of anxiety and depression in women, correlated with infertility per se and with infertility treatments, highlighting predictors of higher levels of distress. Two validated standardized questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of Life (FertiQoL), were administered to 89 women both before their first cycle of infertility treatment and again at the end of the ovarian stimulation for in vitro fertilization (IVF). Women's levels of anxiety were significantly higher before the treatment than during the treatment itself. Stratifying the women in three groups based on principal cause of infertility (male infertility, female infertility, or both male and female), we found significantly higher levels of anxiety and general distress in patients under treatment for female infertility. Higher anxiety levels in our sample before the treatment are probably an effect of not knowing what they are expected to do to solve their problem. Moreover, when the cause of infertility is exclusively female, women experience higher levels of anxiety and general distress both before and during the treatment, probably correlated to a sense of guilt. These data help the treating physician to better counsel patients and to provide a more focused psychological support.",
keywords = "anxiety, FertiQoL, HADS, in vitro fertilization, Infertility, quality of life",
author = "Claudia Massarotti and Giulia Gentile and Chiara Ferreccio and Paola Scaruffi and Valentino Remorgida and Paola Anserini",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/09513590.2018.1540575",
language = "English",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization

AU - Massarotti, Claudia

AU - Gentile, Giulia

AU - Ferreccio, Chiara

AU - Scaruffi, Paola

AU - Remorgida, Valentino

AU - Anserini, Paola

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This study aims to evaluate levels of anxiety and depression in women, correlated with infertility per se and with infertility treatments, highlighting predictors of higher levels of distress. Two validated standardized questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of Life (FertiQoL), were administered to 89 women both before their first cycle of infertility treatment and again at the end of the ovarian stimulation for in vitro fertilization (IVF). Women's levels of anxiety were significantly higher before the treatment than during the treatment itself. Stratifying the women in three groups based on principal cause of infertility (male infertility, female infertility, or both male and female), we found significantly higher levels of anxiety and general distress in patients under treatment for female infertility. Higher anxiety levels in our sample before the treatment are probably an effect of not knowing what they are expected to do to solve their problem. Moreover, when the cause of infertility is exclusively female, women experience higher levels of anxiety and general distress both before and during the treatment, probably correlated to a sense of guilt. These data help the treating physician to better counsel patients and to provide a more focused psychological support.

AB - This study aims to evaluate levels of anxiety and depression in women, correlated with infertility per se and with infertility treatments, highlighting predictors of higher levels of distress. Two validated standardized questionnaires, the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of Life (FertiQoL), were administered to 89 women both before their first cycle of infertility treatment and again at the end of the ovarian stimulation for in vitro fertilization (IVF). Women's levels of anxiety were significantly higher before the treatment than during the treatment itself. Stratifying the women in three groups based on principal cause of infertility (male infertility, female infertility, or both male and female), we found significantly higher levels of anxiety and general distress in patients under treatment for female infertility. Higher anxiety levels in our sample before the treatment are probably an effect of not knowing what they are expected to do to solve their problem. Moreover, when the cause of infertility is exclusively female, women experience higher levels of anxiety and general distress both before and during the treatment, probably correlated to a sense of guilt. These data help the treating physician to better counsel patients and to provide a more focused psychological support.

KW - anxiety

KW - FertiQoL

KW - HADS

KW - in vitro fertilization

KW - Infertility

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85059692524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059692524&partnerID=8YFLogxK

U2 - 10.1080/09513590.2018.1540575

DO - 10.1080/09513590.2018.1540575

M3 - Article

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

ER -